Literature DB >> 22607536

Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis?

M Rudler1, G Rousseau, H Benosman, J Massard, L Deforges, P Lebray, T Poynard, D Thabut.   

Abstract

BACKGROUND: Physiopathology and prognosis of peptic ulcer bleeding (PUB) have never been described in cirrhotic patients. AIM: To assess risk factors and outcome of PUB in two groups of patients with PUB with or without cirrhosis.
METHODS: We included prospectively all patients with PUB referred to our ICU of Hepatology and Gastroenterology between January 2008 and March 2011. All patients were treated according to international recommendations. Diagnosis of cirrhosis was based on clinical, biological and morphological exams. Aetiologies, characteristics and outcomes of PUB were compared in cirrhotic vs. noncirrhotic patients.
RESULTS: A total of 203 patients with PUB were included prospectively. Twenty-nine patients had cirrhosis (group Cirr+), and 174 patients had no cirrhosis (group Cirr-). Demographic data were similar between the two groups except for age and alcohol consumption. Aetiology of cirrhosis was alcohol in 97% of cirrhotic patients. Characteristics of PUB were not different between the two groups. Ninety-three per cent of patients with cirrhosis had endoscopic portal hypertension. Aetiology of PUB was different between the group Cirr+ and Cirr- (Helicobacter pylori = 10.3% vs. 48.8%, P < 0.0001; NSAID's = 17.2% vs. 54.0%, P < 0.0001; idiopathic PUB = 79.3% vs. 23.8%, P < 0.0001). Outcome was comparable concerning re-bleeding (7.0% vs. 6.9%, P = 0.31), need for arterial embolisation (10.3 vs. 8.6%, P = 0.76), need for salvage surgery (0 vs. 1.7%, P = 0.31) and mortality (3.0% vs. 1.1%, P = 0.87).
CONCLUSIONS: Physiopathology of PUB seems to be different in patients with cirrhosis. In cirrhotic patients, PUB occurs almost only in alcoholics. In our series, prognosis was similar to general population. PUB in cirrhosis might be related to portal hypertension and/or alcohol.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22607536     DOI: 10.1111/j.1365-2036.2012.05140.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

1.  Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Alcohol Abuse Increases Rebleeding Risk and Mortality in Patients with Non-variceal Upper Gastrointestinal Bleeding.

Authors:  Jussi M Kärkkäinen; Sami Miilunpohja; Tuomo Rantanen; Jenni M Koskela; Johanna Jyrkkä; Juha Hartikainen; Hannu Paajanen
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

Review 3.  Emergent Transjugular Intrahepatic Portosystemic Shunt Creation in Acute Variceal Bleeding.

Authors:  Mithil B Pandhi; Andrew J Kuei; Andrew J Lipnik; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2020-03-04       Impact factor: 1.513

Review 4.  Gastrointestinal dysfunction in liver cirrhosis.

Authors:  Evangelos Kalaitzakis
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

5.  Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.

Authors:  Shih-Cheng Yang; Chien-Ning Hsu; Chih-Ming Liang; Wei-Chen Tai; Cheng-Kun Wu; Chih-Wei Shih; Ming-Kun Ku; Lan-Ting Yuan; Jiunn-Wei Wang; Kuo-Lun Tseng; Tsung-Hsing Hung; Seng-Howe Nguang; Pin-I Hsu; Deng-Chyang Wu; Seng-Kee Chuah
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

6.  Endoscopic management and outcome of non-variceal bleeding in patients with liver cirrhosis: A systematic review.

Authors:  Georgios Demetiou; Aikaterini Augoustaki; Evangelos Kalaitzakis
Journal:  World J Gastrointest Endosc       Date:  2022-03-16

7.  Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease.

Authors:  Ming-Te Kuo; Shih-Cheng Yang; Lung-Sheng Lu; Chien-Ning Hsu; Yuan-Hung Kuo; Chung-Huang Kuo; Chih-Ming Liang; Chung-Mou Kuo; Cheng-Kun Wu; Wei-Chen Tai; Seng-Kee Chuah
Journal:  BMC Gastroenterol       Date:  2015-05-20       Impact factor: 3.067

8.  Bleeding complications in critically ill patients with liver cirrhosis.

Authors:  Jaeyoung Cho; Sun Mi Choi; Su Jong Yu; Young Sik Park; Chang-Hoon Lee; Sang-Min Lee; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Jinwoo Lee
Journal:  Korean J Intern Med       Date:  2016-01-25       Impact factor: 2.884

Review 9.  Variceal bleeding in cirrhotic patients.

Authors:  Maxime Mallet; Marika Rudler; Dominique Thabut
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-07-21

10.  Association of ABO Blood Type with Bleeding Severity in Patients with Acute Gastroesophageal Variceal Bleeding.

Authors:  Wei-Yu Lin; Ming-Yuan Hong; Chih-Hao Lin; Peng-Peng Chang; Shao-Chung Chu; Chia-Lung Kao
Journal:  Medicina (Kaunas)       Date:  2021-12-03       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.